Peptide-based radionuclide drug conjugate development

A peptide-based radionuclide drug conjugate development platform with novel peptide scaffold and modification that can generate candidate compounds with better pharmacological properties. With our expertise in peptide chemistry, medicinal chemistry and help with AI-drug screening and optimization, we are confident to accelerate the development of better peptide-based radionuclide drug conjugate in terms of efficacy and safety. We are seeking interested parties for collaboration and open for discussion.